In yeast and higher eukaryotes nuclear retention of transcripts may serve in control over RNA decay, nucleocytoplasmic transport and premature cytoplasmic appearance of mRNAs. Hyperadenylation of RNA is known to be associated with nuclear retention, but the cause-consequence relationship between hyperadenylation and regulation of RNA nuclear export is still unclear. We compared polyadenylation status between normal and expanded DMPK transcripts in muscle cells and tissues derived from unaffected individuals and patients with myotonic dystrophy type 1 (DM1). DM1 is an autosomal dominant disorder caused by (CTG)n repeat expansion in the DMPK gene. DM1 etiology is characterized by an almost complete block of nuclear export of DMPK transcripts carrying a long (CUG)n repeat, including aberrant sequestration of RNA-binding proteins. We show here by use of cell fractionation, RNA size separation and analysis of poly(A) tail length that a considerable fraction of transcripts from the normal DMPK allele is also retained in the nucleus (~30%). They carry poly(A) tails with an unusually broad length distribution, ranging between a few dozen to > 500 adenosine residues. Remarkably, expanded DMPK (CUG)n transcripts from the mutant allele, almost exclusively nuclear, carry equally long poly(A) tails. Our findings thus suggest that nuclear retention may be a common feature of regulation of DMPK RNA expression. The typical forced nuclear residence of expanded DMPK transcripts affects this regulation in tissues of DM1 patients, but not through hyperadenylation.
Introduction
Precursors of protein-encoding RNAs (pre-mRNAs) are generally processed to mature mRNAs by 5′ capping, splicing, 3′ polyadenylation and sometimes editing and methylation, during or shortly after transcription by RNA polymerase II [1] [2] [3] . Nuclear export of mature mRNA is thereafter the next posttranscriptional step and a pivotal event in the regulation of gene expression [2, 4] . Proper execution of this entire sequence of events is an important aspect of quality and quantity control in the flow of information from DNA to RNA to protein. Earlier studies have revealed that a considerable fraction of poly(A) RNA is being retained in the nucleus and never reaches the cytoplasm [5] . It took several decades, however, before it was recognized that selective nuclear export of poly(A) RNA offers unique possibilities for quality control, to prevent mRNA from being prematurely released and translated [6] [7] [8] .
During successive steps of mRNA maturation, multiple RNA-binding proteins variably decorate the (pre-)mRNA and engage the transcript in the formation of ribonucleoprotein (RNP) complexes [9] . These RNP complexes can further assemble in larger structures, sometimes termed nuclear bodies, that appear as liquid-phase droplets that form and dissociate by intracellular phase separation [10, 11] . At later moments in the maturation process, export adaptors bind to establish a physical bridge between mRNA and export receptors, ultimately leading to transport of the mRNA to the cytoplasm through the nuclear pore [12, 13] .
Length of the poly(A) tail is a critical parameter in the nuclear and in the cytoplasmic phase of an mRNA's life cycle. On human mRNAs, tails were assumed to consist of 150-250 adenosine nucleotides, but new evidence points to a much shorter median tail length of 50-100 A residues for the majority of mRNAs, lengths of > 250 nucleotides being rare [14] [15] [16] .
Polyadenylation and deadenylation both occur in the nucleus and in the cytoplasm [17, 18] . Nuclear polyadenylation is functionally and structurally coupled to splicing of the terminal intron [19, 20] . Poly(A) tails thus formed serve as binding platform for protein factors and are involved in nuclear surveillance that controls abundance and nucleocytoplasmic export of fully processed mRNAs [21, 22] . In the cytoplasm, the poly(A) tail is involved in regulation of translation efficiency [23, 24] and specification of mRNA fate [25, 26] . Elongation of poly (A) tails of specific mRNAs may occur in the cytoplasm, for example in neurons when localized expression is required and in germ cells and early development when transcription is silenced [18] .
Deadenylation in both nuclear and cytoplasmic compartments is usually coupled to mRNA stability, since the major exonucleasedependent mRNA decay pathway starts with shortening of the poly (A) tail [26] . Short poly(A) tails are not always a signal for decay, however, as non-coding RNAs are known in which a terminal triple helix structure is formed that uses an oligo(A) tail to provide stability [27] . The converse situation, existence of long tails formed by hyperadenylation, has also been observed and is thought to be associated with impaired nucleocytoplasmic export or RNA decay [16] . Whether a long poly(A) tail is the cause or the consequence of nuclear retention is still unclear [28] [29] [30] [31] [32] .
In myotonic dystrophy type 1 (DM1), disease-related DMPK transcripts are retained in the nucleus [33] , triggered by the presence of a long (CUG)n triplet repeat expansion in their 3′ untranslated region (UTR) [34] . Members of the muscleblind-like family (MBNL1-3), DEAD-box helicases and hnRNP proteins associate with this expanded (CUG)n repeat [35, 36] . In turn, this mechanism causes abnormal sequestration of protein factors in RNP complexes, with consequences for faithful nuclear maturation steps of other mRNAs, like alternative splicing and polyadenylation, and processing of miRNAs [36, 37] . Nuclear DMPK (CUG)n RNA retention and aberrant binding in RNP complexes in DM1 tissues are thus tightly coupled processes, as is also manifested by the formation of ribonuclear inclusions, commonly referred to as RNA foci for their appearance in RNA fluorescence in situ hybridization using (CAG)n probes or indirect immunofluorescence assays with anti-MBNL antibodies [33, 38, 39] .
For the study presented here, we hypothesized that expanded DMPK (CUG)n transcripts might be hyperadenylated because of their retention in the cell nucleus. About the fate of normal DMPK mRNAs from unaffected individuals we had no biased idea and therefore decided to include both types of DMPK mRNAs in a parallel study of poly(A) length and nuclear residence. Until now, literature on polyadenylation of (CUG)n-expanded DMPK transcripts is scarce and contradictory findings have been published [40] [41] [42] .
We report here that the nuclear/cytoplasmic distribution ratio of normal DMPK transcripts appeared much higher than for RNAs from housekeeping genes like GAPDH and ACTB, with~30% or more of the total population still being in the nucleus. In line with earlier observations, the population of mutant DMPK mRNAs with long (CUG)n expansions was found almost exclusively in the nucleus (~90%) in our cells with a long mutant DMPK allele. Apparently, these differential distribution profiles were not overtly associated with differences in length of the poly(A) tails as both normal and expanded DMPK mRNAs displayed a similarly broad range of poly(A) tail lengths, ranging between 0 and > 500 nucleotides (between 200 to up to 500 in the nucleus). We therefore conclude that the dominant effects that (CTG)n repeat expansion has on residence time have no bearing on poly(A) tail lengths of DMPK RNAs.
Materials and methods

Human material
Human tissue material was obtained from preconsented post-mortem donors for research purposes in accordance with local guidelines. No additional approval by an ethics committee was required at that time (~18 years ago). Heart and psoas muscle autopsies were obtained from a congenital DM1 twin with a confirmed clinical and DNA diagnosis related to an expanded DMPK (CTG)n repeat of about 1300 triplets (normal alleles contained 5 and 12 triplets, respectively). Tissues were snap frozen immediately after collection and stored between minus 80 and 135°C until further use. A skeletal muscle sample from an unaffected anonymous donor ((CTG)11/(CTG)12) from our own repository was included in the study. This sample was collected long before the current guidelines for written consent were enforced and no detailed information could be traced.
Cell culture
Immortalized human LHCN-M2 myoblasts ((CTG)5/(CTG)5) [43] and DM11 cl5 myoblasts ((CTG)13/(CTG)2600) [44] were a gift of Drs V. Mouly and D. Furling. Myoblasts were grown on 0.1% (w/v) gelatincoated dishes in skeletal muscle cell basal medium (PromoCell) with Supplement Mix (0.05 mL/mL fetal calf serum, 50 μg/mL bovine fetuin, 10 ng/mL recombinant human epidermal growth factor, 1 ng/mL recombinant human basic fibroblast growth factor, 10 μg/mL recombinant human insulin, 0.4 μg/mL dexamethasone; PromoCell) supplemented with 1% (v/v) GlutaMax and 15% (v/v) bovine growth serum (Thermo Scientific) at 7.5% CO 2 and 37°C.
Primary DM1 myoblasts ((CTG)13/(CTG)800), also a gift of Dr. D. Furling [45] , were grown on 0.1% (w/v) gelatin-coated dishes in Ham's F10 medium (Gibco) supplemented with GlutaMax and 20% (v/v) bovine growth serum (Thermo Scientific) at 7.5% CO 2 and 37°C.
RNA isolation and subcellular fractionation
Total RNA from muscle tissue and cultured cells was isolated using TRIzol reagent (Invitrogen) and Aurum Total RNA Mini Kit (Bio-Rad), respectively, according to manufacturer's instructions. Ethidium bromide staining of isolated RNA on agarose gel always demonstrated distinct 28S and 18S rRNA signals. 28S/18S ratios for RNA isolated from long-frozen psoas and heart tissue were 2.2 ± 0.4 (n = 6).
For RNA isolation from subcellular fractions, myoblast cultures were grown to 80% confluence, collected by trypsinization and pelleted by centrifugation at 1000 ×g for 5 min at 4°C. Pellets were washed twice with ice-cold PBS. The cell pellet was resuspended in ice-cold cell disruption buffer [46] (hypotonic solution with 10 mM KCl, 1.5 mM MgCl 2 , 20 mM Tris-Cl (pH 7.5), 1 mM DTT) and incubated on ice for 10 min. Cells were homogenized with a chilled Dounce homogenizer (tight pestle, 0.025-0.076 mm; Wheaton) for 15 strokes and then a final concentration of 0.1% Triton X-100 was added. The lysate was spun at 1500 ×g for 5 min at 4°C. The supernatant (cytoplasmic fraction) and the pellet (nuclear fraction) were each diluted in lysis buffer belonging to the Aurum Total RNA Mini Kit and RNA was isolated according to manufacturer's protocol.
SDS-PAGE and western blotting
Proteins in the subcellular fractions were resolved on 10% SDS-PAGE gel and electrotransferred to PVDF membrane (Amersham GE Healthcare). Membranes were blocked with 3% bovine serum albumin in PBST (PBS with 0.1% Tween-20) and incubated overnight with lamin A + C antibody (ab40567, Abcam), β-tubulin monoclonal antibody (E7, Developmental Studies Hybridoma Bank, University of Iowa, USA) diluted in the same buffer. After washing in PBST, blots were incubated with appropriate fluorescently labeled secondary antibodies and washed in PBST and PBS. Signals were detected using the Odyssey® Infrared Imaging System (LI-COR Biosciences).
RNA extraction from gel
For size fractionation of RNA via agarose gel electrophoresis, total RNA was denatured at 70°C for 10 min in 50% (v/v) deionized formamide and 1× MOPS, and supplemented to an end concentration of 13 ng/μL ethidium bromide, 4.2% (w/v) Ficoll PM 400 and 0.07% (w/v) bromophenol blue. RNA was loaded onto a MOPS-buffered 1% agarose gel and run until 28S and 18S rRNAs were clearly separated.
We had to work without formaldehyde in the gel to avoid chemical modification of RNA [47] that would impede downstream applications such as RT-PCR. Absence of formaldehyde could leave RNA partially folded during electrophoresis and especially expanded DMPK mRNAs might form different topological structures and migrate anomalously. For our assay, however, structure effects on DMPK RNA migration appeared not to be a confounding problem and RNA migrated at expected positions in size ladders (Suppl. Fig. 1 ). After electrophoresis, the gel was cut across the position of 28S rRNA and top (RNA size >~5 kb) and bottom (RNA size~0.1-~5 kb) gel sections were collected (illustrated in Fig. 1 ), from which RNA was extracted using the ZymoClean™ Gel RNA Recovery Kit (ZymoResearch) according to manufacturer's instructions. Briefly, gel slices were dissolved in RAD Buffer™ at 55°C and transferred to a silica membrane spin column to allow RNA binding. After several washing steps, RNA was eluted from the column in water. Successful top-bottom fractionation was verified by running RNA aliquots on a 1% MOPS-buffered agarose gel.
RNase H assay
DMPK and GAPDH mRNAs were trimmed at specific locations using RNase H to allow for a measurable shift in electrophoretic mobility depending on poly(A) tail length, according to a protocol described by Murray and Schoenberg [48] . Per reaction, an equivalent of 5-35 μg total RNA was mixed with 5 pmol DMPK primer (5′-GCACTTTGCGAA-CCAACG-3′), 5 pmol GAPDH primer (5′-CTGCTTCACCACCTTCTTGA-TGTCATC-3′) and optionally 5 pmol (dT)18 (5′-TTTTTTTTTTTTTTTT-TT-3′) in a final volume of 25 μL. Per sample, 10 units RNase H (Ambion), 30 units RNaseOUT™ (Invitrogen) and RNase H buffer were added to a final concentration of 20 mM HEPES-KOH (pH 8), 50 mM KCl, 4 mM MgCl 2 and 1 mM DTT. The reaction was incubated at 37°C for 1 h and terminated via addition of 1 μL 0.5 M EDTA. RNA was purified by organic extraction using phenol chloroform (1:1) and precipitated in NaAc (pH 5) and ethanol.
Poly(A) RNA selection
Poly(A)-selected RNA was isolated from total RNA using the NucleoTrap® mRNA kit (Macherey-Nagel). In short, total RNA was incubated with oligo(dT) latex beads, allowing binding of the beads to poly(A) tails of transcripts. After several washing steps using a microfilter to trap the latex beads, poly(A)-selected RNAs were eluted from the beads in water. Size-fractionated CDM RNA in which DMPK mRNAs were specifically trimmed with RNase H was also subjected to poly(A) selection. To minimize the amounts of processed CDM RNA required for input in the procedure, mouse total RNA was mixed in and used as carrier RNA.
Poly(A) fractionation
Total RNA was fractionated with respect to poly(A) tail length, based on a protocol described by Meijer et al. [14] and the PolyATtract® mRNA Isolation System (Promega). Total or size-fractionated RNA (24-30 μg in 185 μL), with DMPK and GAPDH transcripts trimmed using the RNase H assay, was denatured at 65°C for 10 min. 20 × SSC (Promega) was added to a concentration of 1× SSC and biotinylated oligo(dT) (Promega) was added to a final concentration of 9.4 pmol per μg total RNA. The solution was gently mixed and incubated at room temperature until completely cooled. Streptavidin-paramagnetic particles (Promega) were washed three times with 0.5× SSC and resuspended in 1× SSC. Each RNA sample was added to 600 μL particles and incubated at room temperature while rotating. The unbound fraction was collected after 10 min. Beads were washed three times in 0.5 × SSC, followed by elution of poly(A)-selected RNA using buffers containing decreasing concentrations of SSC. Beads were kept rotating in between elution steps for at least 5 min. All elution steps were performed at room temperature. All fractions were saved, stored on ice and ultimately precipitated in presence of 10 μg yeast tRNA as carrier in NaAc (pH 5) and ethanol. Heat-and formamide-denatured psoas muscle RNA from a CDM patient (input, In) was electrophoresed on agarose gel (1), followed by excision of the desired gel fragments guided by migration of 28S rRNA (2) . Each lane was sliced in two fractions, one containing RNA that migrated slower than 28S rRNA (Top) and the other containing RNA that migrated faster than 28S rRNA (Bottom, Bot). RNA was then extracted from the gel slices (3). Recovered RNA from the two fractions was analyzed on an ethidium bromide-stained agarose gel using UV exposure to visualize rRNA (4) and on northern blot using hybridization with a DMPK probe (5).
Northern blotting
Northern blotting was performed according to standard procedures. Per lane, an equivalent of 10 μg total RNA, denatured in 50% (v/v) deionized formamide and 6.7% (w/w) formaldehyde, was subjected to electrophoresis in a 1.2% agarose gel with 6.7% (w/w) formaldehyde. RNA was transferred to Hybond-XL nylon membrane (Amersham Pharmacia Biotech), by capillary transfer in 10 × SSC and then the blot was UV crosslinked (Stratalinker® UV Crosslinker, Stratagene). The northern blot was hybridized with random-primed 32 P-labeled probes (2.6 kb DMPK cDNA, covering the entire ORF and 3′ UTR, and the complete 1.9 kb 18S rRNA cDNA). Hybridization was carried out in Church-Gilbert buffer (0.25 M Na 2 HPO 4 (pH 7.2), 7% (w/v) SDS, 1 mM EDTA (pH 8.0)). RNase H-trimmed DMPK and GAPDH RNAs were visualized using an alternative northern blotting procedure. Per lane, an equivalent of 5-35 μg total RNA, denatured in 50% (v/v) deionized formamide, was subjected to electrophoresis in a 1× TBE-buffered 4% polyacrylamide gel with 8 M urea. RNA was blotted to Hybond-XL nylon membrane by semi-dry electrophoretic transfer (Trans-Blot® SD Cell, Bio-Rad). The blot was UV crosslinked and hybridized with random-primed 32 Plabeled probes (a cDNA fragment representing the 3′ terminal 335 nucleotides of DMPK exon 15 and a 1.2 kb GAPDH cDNA, covering the entire ORF and parts of the flanking UTRs) or a 32 P-end-labeled oligonucleotide complementary to a segment in the 3′ UTR of GAPDH (5′-CATGAGGTCCACCACCCTGTTGCTGTAG-3′). Hybridization was done in 6 × SSC, 10 × Denhardt's reagent [49] (0.2% bovine serum albumin, 0.2% Ficoll 400, 0.2% polyvinylpyrrolidone), 0.2% SDS and 100 μg/mL herring sperm DNA. Signals from both northern blot assays were visualized by Phosphor-Imager analysis (Molecular Imager FX, Bio-Rad) and analyzed with Quantity One (Bio-Rad) and FIJI software [50] .
RT-PCR
RNA was reverse transcribed using the iScript™ cDNA Synthesis Kit (Bio-Rad). For analysis of size-fractionated total and poly(A)-selected RNA, an equivalent of 500 ng total RNA was used as input. For analysis of nuclear and cytoplasmic RNA samples, 500 ng cytoplasmic RNA and an equivalent of nuclear RNA was used as input. For qPCR, 3 μL 10-50-fold diluted cDNA preparation was mixed in a final volume of 10 μL containing 5 μL iQ™ SYBR® Green Supermix (Bio-Rad) and 4 pmol of each primer (ACTB ex2-ex3, 5′-CGGGCCGTCTTCCCCTCCAT-3′ and 5′-TGGGCCTCGTCGCCCACATA-3′; ACTB in2-ex3, 5′-CGTGC TCAGGGCTTCTTGTC-3′ and 5′-CCTCGTCGCCCACATAGGAA-3′; DMPK ex1-ex2, 5′-ACTGGCCCAGGACAAGTACG-3′ and 5′-CCTCCTTAAGCCTCACCACG-3′; DMPK ex15 5′ from (CUG)n repeat, 5′-AGAACTGTCTTCGACTCCGGG-3′ and 5′-TCGGAGCGGTT GTGAACTG-3′; DMPK ex15 3′ from (CUG)n repeat, 5′-TGCCTGCTTACTCGGGAAATT-3′ and 5′-GAGCAGCGCAAGTGAGGAG-3′; GAPDH ex1-ex2, 5′-CCCGCTTCGCTCTCTGCTCC-3′ and 5′-CCTTCCCCATGGTGTCTGAGCG-3′). Samples were analyzed using the CFX96 Real-time System (Bio-Rad). A melting curve was obtained for each sample in order to confirm single product amplification. Samples from no-template and no-reverse transcriptase reactions were included as negative controls.
PCR on DMPK splice isoforms
For analysis of DMPK isoform abundance, a semi-quantitative PCR using Q5® High-Fidelity DNA Polymerase (NEB) was performed on cDNA, including a no-reverse transcriptase control. Four regions of DMPK were analyzed: ex1-ex7 (5′-CGAACTGGCCCAGGACAAGTA-3′ and 5′-TACACCCAGCGCCCACCAGT-3′) [51] , ex7-ex9 (5′-ACGGCGGA-GACCTATGGCAA-3′ and 5′-TCCCGAATGTCCGACAGTGT-3′) [51] , ex9-ex12 (5′-CTGTCGGACATTCGGGAAGGT-3′ and 5′-CAACTCCATCC-GCTCCTGCAA-3′) and ex12-ex15 (5′-GAACCGGGACCTAGAGGCACA-CGT-3′ and 5′-TCGGAGCGGTTGTGAACTG-3′). PCR products were visualized after electrophoretic separation on a 2-3% agarose gel by staining with ethidium bromide followed by image analysis using FIJI software.
RT reaction and PCR across poly(A) tail
To determine poly(A) tail length using an RT-PCR approach, 10 or 50 pmol (dT)10 adapter primer (5′-GGGGATCCGCGGTTTTTTTTTT-3′) [48] was mixed with 500 ng total RNA and allowed to anneal. Primers on polyadenylated RNAs were then extended by reverse transcription using SuperScript III Reverse Transcriptase (Life Technologies). cDNAs thus formed were used as template in a PCR, using Q5® High-Fidelity DNA Polymerase (NEB), with a DMPK (5′-TGCCTGCTTACTCGGGAAA-TT-3′) or GAPDH (5′-CATGTAGACCCCTTGAAG-3′, Bioo Scientific) forward primer. No additional reverse primer was added, so the (dT) 10 adapter primer from the RT reaction functioned as reverse primer. cDNA samples from no-template control and no-reverse transcriptase control were included. PCR fragments were separated on an ethidiumbromide stained 1.5-3% agarose gel. Additionally, PCR products were transferred to Hybond-XL nylon membrane (Amersham Pharmacia Biotech) and hybridized with 32 P-end-labeled oligonucleotides (DMPK, 5′-TCAGCGAGTCGGAGGACGAGG-3′; (dT)18, 5′-TTTTTTTTTTTTTTTT-TT-3′). Signals were visualized by Phosphor-Imager analysis and analyzed with Quantity One (BioRad) and FIJI [50] software.
Results
Separation of normal and triplet repeat expanded DMPK transcripts
To investigate differential effects of (CTG)n-repeat length on polyadenylation of DMPK transcripts, we developed a size fractionation method to independently analyze normal and expanded DMPK mRNAs, as they occur in RNA isolated from DM1 cells (Fig. 1) . A complicating factor in this procedure may seem the length heterogeneity in the population of DMPK mRNAs, which is a mix of alternatively spliced transcripts [52, 53] . This heterogeneity is fortunately not a concern for the analysis of RNA from cells of patients with classical or congenital DM1. Their cells carry large (CTG)n repeat expansions, causing the (CUG)n repeat tract in mutant DMPK transcripts to contribute more to mRNA length variation than alternatively spliced exon sequences. The total mix of DMPK mRNAs in DM1 cells with long repeat expansion can thus be broken up into two distinct populations, having either normal or expanded repeat tracts and non-overlapping length distributions. We expected DMPK mRNAs with repeats > 800 triplets to move slower than 28S rRNA (~5 kb), whereas normal DMPK mRNAs would migrate between the 18S (~2 kb) and 28S rRNA size markers.
To validate our fractionation method, we subjected RNA from muscle tissue from a congenital DM1 (CDM) patient with (CTG)12/ 1300 alleles to agarose gel electrophoresis. Our results confirmed that the migration of 28S rRNA indeed formed a convenient demarcation point (Suppl. Fig. 1 ). Normal and expanded DMPK transcripts were separated and appeared faithfully represented among the RNAs that migrated faster (Bottom fraction) or slower (Top fraction) than 28S rRNA (Fig. 1) . A silica-membrane-based purification method for recovery of RNA from the gel slices proved to be highly efficient. The long (CUG)n repeat had no detectable influence on RNA yield (unpublished data).
Normal and expanded DMPK transcripts are similarly spliced in DM1 tissues
Nuclear polyadenylation is strongly coupled to splicing of the last intron [19, 20] . In fact, the 3′ end of DMPK pre-mRNA is subject to developmentally regulated and tissue-specific alternative splicing [52, 54] . Since this situation might thus be coupled to poly(A) site choice or polyadenylation efficiency, we examined whether DMPK mRNA splice modes were altered in cis by (CTG)n repeat length. RT-PCR analysis of size-fractionated RNA preparations from heart and psoas muscle from a CDM patient revealed that there existed essentially no difference between splicing profiles of normal and expanded DMPK transcripts (Fig. 2) . Furthermore, we found no evidence for alternative poly(A) site choice in DMPK mRNA from own experimental data nor from bioinformatic analyses in databases (unpublished data). Taken together, these data indicate that splice changes do not contribute to 3′ end sequence differences or overall size changes in the population of normal and expanded DMPK transcripts in DM1 cells.
(CUG)n repeat length influences oligo(dT)-mediated poly(A) RNA selection
To assess whether poly(A) tail length of normal and expanded DMPK mRNAs might be different, we subjected RNA from CDM patient heart and psoas muscle to poly(A) selection using oligo(dT) beads. Northern blot analysis demonstrated that 18S rRNA was, as anticipated, completely absent in the poly(A)-selected RNA fraction (Fig. 3A,B) . A DMPK probe showed that normal DMPK transcripts (~2.8 kb) were efficiently (75-95%) recovered in the poly(A)-selected fraction, in contrast to expanded DMPK transcripts (~7 kb; 40-60%). One explanation for this observation would be that only a fraction of expanded DMPK mRNAs was polyadenylated. More likely, a considerable portion of the long expanded DMPK mRNAs was broken during experimental handling and only poly(A) tail-containing 3′ fragments of variable size were captured by the beads. Influence of the expanded (CUG)n repeat on oligo(dT) binding avidity, caused by topological constraints in the expanded transcripts, could not be excluded at this point.
In an alternative approach, we started with separation of intact normal and expanded DMPK transcripts by size fractionation. Cleavage by RNAse H at a site downstream of the (CUG)n repeat was subsequently used to separate the 5′ ends of the transcripts, including the (CUG)n repeat, from the 3′ ends carrying the poly(A) tails under investigation (Fig. 3C,D) . Poly(A) selection by binding to oligo(dT) beads was subsequently performed for each size fraction. DMPK-specific sequences in the bottom and top fractions and in the poly(A)-selected cleaved RNA fragments were monitored by RT-qPCR, using amplicons 5′ and 3′ of the RNase H-cleavage site (Fig. 3D) . The 3′ amplicon indeed gave similar yields for normal and expanded DMPK transcripts in poly (A)-selected fractions (Fig. 3E) . Signals from the 5′ amplicon were completely absent after oligo(dT) selection, as expected. Total yield was low for both DMPK RNAs but also for GAPDH mRNA, included as a control. Combined, these data indicate that equal fractions of normal and expanded DMPK mRNAs bear a poly(A) tail.
DMPK transcripts have a long residence time in the nucleus
Next, we investigated the relationship between poly(A) tail length and subcellular localization of DMPK mRNAs. We used cultured myoblasts, since reliable cell fractionation of nuclear and cytoplasmic content is difficult to perform on muscle tissue [46] . Unaffected LHCN (CTG)5/5 myoblasts and DM1 myoblasts with (CTG)13/800 or (CTG) 13/2600 DMPK alleles were separated in nuclear and cytoplasmic fractions, followed by RNA extraction. Western blot analysis demonstrated successful cell fractionation: β-tubulin protein was strongly enriched in the cytoplasmic fraction (> 85%), whereas lamin A and lamin C appeared almost exclusively in the nuclear fraction (> 95%; Suppl. Fig. 2) .
A relatively large fraction of DMPK (CUG)5 transcripts was localized in the nucleus (~30%; Suppl. Fig. 3 ), compared to the situation for transcripts from regular housekeeping genes ACTB and GAPDH (~10%). In DM1 myoblasts, a higher proportion of DMPK mRNA molecules was nuclear (~60%; Suppl. Fig. 3 ). This higher percentage represents the superimposed behavior of normal and expanded DMPK RNAs, the latter of which almost exclusively reside in the nucleus [40, 41] . Combined with the data from LHCN cells, we conclude that in patient cells 20-30% of normal and 90-100% of expanded DMPK transcripts localize in the nucleus.
Poly(A) tails of DMPK mRNAs in myoblasts show a broad length distribution
To measure poly(A) tail length of DMPK mRNA and draw a comparison with the poly(A) tail length of GAPDH mRNA, we used RNAse H cleavage to produce relatively small 3′ end fragments of 400 nt + poly(A) tail. Variation in poly(A) length on such small fragments would cause a relatively major shift in mobility, easily detectable on northern blot. For reference, a (dT)18 primer was included during cleavage to completely remove the poly(A) tail in some samples. Next to the nuclear cytoplasmic fractionation, RNA from DM1 myoblasts was also size-fractionated to allow for separate measurement of tails of normal and expanded DMPK mRNAs (Fig. 4A) .
A smear of fragments representing a broad heterogeneity in poly(A) tail length for DMPK RNA was observed for both normal and DM1 samples (Fig. 4B-D) . Discrete bands matching the expected size of the DMPK RNA 3′ end were only visible after treatment with the (dT)18 primer. To our surprise, we observed only a minor difference in poly(A) tail length distribution between nuclear and cytoplasmic DMPK transcripts. Nuclear DMPK mRNAs primarily carried long poly(A) tails in the 200-500 nt range, whereas the poly(A) tail length distribution of cytosolic DMPK mRNAs extended more towards shorter lengths in the 50-500 nt range. Also in DM1 cells, poly(A) tails on DMPK RNA were long, up to > 500 nt, with only marginal differences between length profiles of normal and expanded DMPK transcripts (Fig. 4C,D) . The poly (A) tail length distribution of GAPDH mRNA showed a more restricted To verify these poly(A) tail length measurements, we also used a dedicated RT-PCR approach [48] . Total RNA from unaffected myoblasts was subjected to reverse transcription using a (dT)10 adapter primer, which could hybridize anywhere along the poly(A) tail. PCR amplification using the same (dT)10 oligonucleotide as reverse primer and a DMPK-or GAPDH-specific forward primer produced a smear of products on blot, reflecting the familiar length heterogeneity of poly (A) tails (Suppl. Fig. 4 ). Although this analysis is somewhat biased, because shorter poly(A) tails form shorter amplicons and get preferentially amplified, it clearly supports the remarkable length distribution of DMPK mRNA poly(A) tails in actively proliferating myoblasts.
DMPK mRNA poly(A) tails in DM1 muscle also show the unusually broad length distribution
We sought to confirm that this atypical broad poly(A) length profile is representative for DMPK mRNAs in muscle tissue in vivo, i.e. in noncycling cells in the G0-phase. The polyadenylation status of DMPK mRNAs was therefore studied in skeletal muscle from a CDM patient. Combined use of RNA size fractionation, RNase-H mediated trimming and gel electrophoresis confirmed the broad distribution of poly(A) tail lengths on both normal and expanded DMPK transcripts (Fig. 5) . Alike in RNA isolated from proliferating myoblasts, poly(A) tail lengths of 0 to > 500 nucleotides were identifed, whereas GAPDH RNA from the same muscle contained poly(A) tails of 0-200 nucleotides.
To verify these observations we applied poly(A) fractionation based on differential binding to oligo(dT) beads, proportional to tail length [14] . Total RNA was RNase-H trimmed, mixed with biotinylated (dT)n primer to allow hybridization with poly(A) tails, after which streptavidin-coated beads were used to capture oligo(dT)-bound transcripts. Poly(A)+ RNA was eluted in fractions using buffers of decreasing salt concentration. Application of this procedure to RNA from CDM heart corroborated the broad distribution of poly(A) tail lengths of DMPK RNAs, with a range of 0 to > 650 nucleotides, whereas tails of < 200 nucleotides were found for GAPDH transcripts (Fig. 5B) . In CDM skeletal muscle, similar profiles were observed for normal and expanded DMPK transcripts, with the longest poly(A) tails appearing on expanded DMPK mRNAs, thus corroborating our findings with the other approaches (Fig. 5C ).
Discussion
RNA toxicity due to expression of a mutant DMPK allele with an expanded (CTG)n trinucleotide repeat is seen as the main trigger for pathobiology in DM1 [55] . To understand how this toxicity leads to compromised cell function, detailed study is needed of possible differential mechanistic events involved in fate specification of expanded versus normal DMPK transcripts. Each type of transcript may follow entirely different routes through the nucleus, triggered by RNA topology and decoration with RNA-binding proteins, potentially dependent on length of the (CUG)n tract. Previous studies on DMPK mRNA production have already made clear that long DMPK transcripts remain predominantly trapped in the nucleus, while normal DMPK mRNAs are exported to the cytosol to be translated [33, 36, 40] .
Here we deconvoluted the complexity of DMPK RNA fate, through analysis on polyadenylation of expanded and normal DMPK mRNA copies. Based on prior evidence on DMPK expression and data on the 3D ) with (w/) and without (w/o) (dT)18 primer and analyzed on northern blot. (B) Poly(A) tail length analysis of DMPK and GAPDH transcripts in unaffected myoblasts as described in (A), except that the size-based RNA separation step could be omitted for this cell type. Defined fragments for DMPK (~350 nt) and GAPDH (~430 nt) transcripts were observed in the presence of (dT)18 primer (i.e., without poly(A) tail, 0 As). A broad smear characteristic for poly(A) tail length heterogeneity was observed in absence of (dT)18, illustrated with a plot profile on the right (colors correspond with colors above the lanes) and an poly(A) tail length on the left. (C,D) Northern blot analysis of the procedure described in (A) for DMPK and GAPDH transcripts in 13/800 and 13/2600 DM1 myoblasts.
relationship between polyadenylation and nuclear residence of other RNAs [29] [30] [31] , we aimed to reveal a possible correlation between poly (A) tail length and nuclear retention. Moreover, we hoped to learn whether presence of a (CUG)n expansion would exert cis effects on polyadenylation of DMPK mRNA. It had already been reported that expanded DMPK transcripts do undergo polyadenylation, but these findings were not conclusive [40] [41] [42] . Besides, data on poly(A) tail length distribution of DMPK mRNAs and effects of (CUG)n repeat expansion or intracellular distribution were not provided in these reports.
We applied combinations of basic methods to separate normal and expanded DMPK transcripts and to isolate nuclear and cytoplasmic RNA. Size fractionation based on differential RNA migration behaviour under partially denaturing conditions enabled us to discriminate between mature normal and expanded transcripts in DM1 cells. Any length heterogeneity as a result of alternative DMPK splice modes [52, 53] were compensated for by the long (CUG)n repeat. We estimate that any defined expansion of > 300 triplets (i.e.~1000 nt length difference) would enable us to perform separation of normal and expanded transcripts. This method may therefore also be applicable for separating transcripts in other repeat disorders, provided that the corresponding expansion makes up for other heterogeneities in the transcript population, e.g. caused by alternative transcription initiation, splicing or polyadenylation.
For our comparative analysis we chose proliferating myoblasts (control and DM1) and skeletal and cardiac muscle biopsies from CDM patients with relatively large expansions. These cells and tissues are particularly relevant for the muscle and heart problems in DM1 patients. Also, somatic instability is essentially absent in proliferating myoblasts and cannot yet have been very active in young CDM tissues, ensuring DMPK RNA populations with relatively defined (CUG)n repeat length (compare expanded DMPK RNA smears from adult tissues on blots in [56] ).
Mature mRNAs generally carry poly(A) tails with lengths that range between 0 and 200 residues [14, 57] . This range is in accordance with what we and others [28] have determined for the poly(A) tail of GAPDH mRNA. For DMPK mRNAs we observed a significantly broader range, between a few and > 500 A residues. Although tails of several hundreds of As are unusual for most mRNAs, they have been observed for other RNAs, including nuclear long noncoding RNAs NEAT1 and XIST [28] . Since polyadenylation normally occurs in the nucleus and deadenylation mainly takes place in the cytoplasm, the distribution of poly(A) tail lengths may provide clues on transcript routing and residence in these two cellular compartments. Our observation that DMPK mRNA isolated Fig. 5 . DMPK transcripts in CDM skeletal muscle and heart also contain a long poly(A) tail.(A) Northern blot analysis of RNase H assay on DMPK and GAPDH transcripts in sizefractionated RNA from CDM psoas tissue. RNase H assay was performed in presence (w/) and absence (w/o) of (dT)18 primer. Normal (Bottom, Bot) and expanded (Top) DMPK transcripts were analyzed separately. GAPDH transcripts served as reference. A plot profile is indicated on the right (colors correspond with colors above the lanes). (B,C) Northern blot analyses of poly(A)-fractionation assays using RNase H-trimmed RNA from CDM heart (B) and size-fractionated RNA from CDM psoas (C). RNAs were subjected to oligo(dT)-affinity chromatography and eluted with decreasing salt concentrations. Normal (Bottom, Bot) and expanded (Top) DMPK transcripts were analyzed separately in (C). Approximate poly(A) tail lengths are indicated on the left. GAPDH transcripts served as reference.
from myoblast nuclei had slightly more uniform and longer poly(A) tails than cytoplasmic DMPK mRNA is in keeping with the idea that polyadenylation of DMPK transcripts follows the normal processing route.
A fairly large percentage (~30%) of the pool of normal DMPK transcripts had a nuclear location, much more than observed for ACTB and GAPDH transcripts. Either rapid cytoplasmic decay or slow nuclear processing and export may explain this unusual distribution profile. We consider the first option unlikely, since DMPK mRNAs are rather stable with a half-life of 7-24 h in LHCN-M2 cells (unpublished data) which matches data found for other cell types [40, 58, 59] . The second explanation for the high fractional content of DMPK mRNA in the nucleus would be slow nuclear processing, perhaps with a role in prevention of premature cytoplasmic release [60] . Earlier we have found that forced overproduction of DMPK isoforms has detrimental effects on mitochondrial clustering and cell viability [61, 62] . Hence, it is tempting to speculate that slow nuclear release of DMPK mRNA might regulate timing and level of DMPK protein production. More work is necessary to provide any support for this speculation.
Abnormal nuclear retention of transcripts can lead to a process called hyperadenylation [29] [30] [31] . For example, transcripts produced from a mutant beta-globin intronless gene are retained in the nucleus, because of inefficient transport to the cytoplasm. These beta-globin transcripts subsequently undergo hyperadenylation as a mark for rapid decay [28] . Hyperadenylation may also be uncoupled from subsequent decay, however, as shown for other transcripts [28] . We feel it is necessary to point out that the term hyperadenylation should be reserved for abnormal elongation of transcripts under specific (patho) biological conditions. For the synthesis of the unusually long poly(A) tails on normal DMPK mRNAs we do not consider this an appropriate term.
The situation may be different for expanded DMPK RNAs in cells of DM1 patients. We expected to find a link between the block in nuclear export of mutant DMPK transcripts captured in abnormal RNP complexes (i.e. formed by aberrant association with MBNL1-3 and other proteins) and hyperadenylation [28] [29] [30] [31] [32] . Surprisingly, analysis of poly (A) tail lengths in expanded versus normal DMPK transcripts did not reveal overt differences in poly(A) processing: both populations carried poly(A) tails that fall in an exceptional broad length range and prolonged nuclear retention obviously is not associated with additional hyperadenylation.
Expanded DMPK transcripts may be physically trapped in the nucleus and therefore unable to reach nuclear compartments where hyperadenylation occurs. We consider this scenario unlikely as others have shown that expanded DMPK mRNAs predominantly locate at the periphery of nuclear speckles (SC-35 domains), while normal DMPK transcripts traverse through these domains [63, 64] . This finding together with our observation that expanded DMPK transcripts are normally spliced suggests that export of expanded DMPK mRNA is blocked at an early step in intranuclear transport, yet in a phase after completion of RNA processing. A more likely explanation thus is that polyadenylation is already largely completed before mutant DMPK RNAs get trapped (while normal DMPK RNAs are transported further to the nuclear pores). A blockade in transport would thus not result in differential effects on poly(A) length. Finally, we cannot exclude the possibility that hyperadenylation does not occur in muscle cells or only occurs on mRNAs with specific features or sequences absent in DMPK mRNAs.
In conclusion, further study is required regarding the role of nuclear residence and the exceptionally long poly(A) tails, which we present here as dominant features in the life cyle of normal and expanded DMPK mRNAs in muscle cells. We need to know what the exact sequence is of RNA processing steps of normal DMPK mRNAs and the role of different RNA-binding proteins therein. These events need to be distinguished from steps involved in the selective capturing of long expanded mRNAs in the nucleus. Only then can we better understand why (CUG)n repeat length has no differential effect on polyadenylation and splicing of mutant and normal DMPK transcripts.
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